Dalal Street Blogs provides information for educational purposes only and does not constitute investment advice. Please consult a SEBI-registered investment adviser before making any investment decisions.
CAUTION: Dalal Street Blogs publishes market news and educational content only. We do not promote, recommend or endorse any stock, and nothing here is a solicitation to buy or sell securities. Please consult a SEBI-registered adviser before investing.
Market News

UPL Q2 Results: EBITDA Up 5% to ₹2,312 Crore as Revenue Dips 1% (Nov 2, 2026)

4066
By Dalal Street Blogs Editorial3 min read

UPL Q2 results landed on Monday, November 2, 2026, and they tell two stories at once. Consolidated revenue for the July-September quarter slipped 1% year on year to ₹11,860 crore, yet EBITDA rose 5% to ₹2,312 crore as margins widened. The agri-solutions company’s press release filed with NSE calls it the eighth straight quarter of margin and EBITDA growth.

In this article
  1. UPL Q2 results: the headline numbers
  2. Where the growth came from, and where it didn’t
  3. The half-year view and the balance sheet
  4. What it means

UPL Q2 results: the headline numbers

Here is what the company reported for Q2 FY27, with every change compared against the same quarter last year:

  • Revenue: ₹11,860 crore, down 1% from ₹12,019 crore.
  • Contribution: ₹5,087 crore, up 1%. Contribution margin was 42.9%, up 100 basis points.
  • EBITDA: ₹2,312 crore, up 5%. EBITDA margin was 19.5%, up 120 basis points.
  • Operational PATMI (profit after tax and minority interest, excluding exceptional items): ₹422 crore, up ₹11 crore.

UPL puts the flat topline down to a fall in global crop protection volumes, partly offset by a favourable currency effect. Lower SG&A spending helped absorb higher input costs, which is how margins still moved up.

Where the growth came from, and where it didn’t

The split by business is where it gets interesting. UPL Corporation, its largest platform by revenue, saw revenue fall 8% to ₹7,972 crore and its EBITDA drop 14% to ₹1,083 crore. The company blamed bad weather and the phasing of sales in Brazil and other Latin American markets, and drought-like conditions in Europe.

The other platforms carried the quarter. Seeds business Advanta grew revenue 12% to ₹1,875 crore, with EBITDA up 19% to ₹510 crore. SUPERFORM, which houses the specialty chemicals business, grew revenue 28% to ₹3,579 crore and EBIT 39% to ₹323 crore. UPL SAS was roughly flat, with revenue up 1% at ₹921 crore.

By region, Latin America is still the biggest piece at ₹5,214 crore, down 8%. By our arithmetic that is about 44% of the quarter’s revenue. North America and Rest of the World each grew 19%. Europe fell 12% and India fell 9% to ₹1,509 crore.

The half-year view and the balance sheet

Over the first half of FY27, revenue rose 4% to ₹22,041 crore, EBITDA rose 9% to ₹3,812 crore and operational PATMI was ₹441 crore, up 33%. India grew 5% for the half, even after the weak second quarter.

The balance sheet is the part we would watch. Net debt stood at ₹28,684 crore ($2,993 million) at the end of September, up ₹4,882 crore from a year earlier. Net debt to EBITDA rose to 2.9x from 2.7x, and net working capital stretched to 145 days from 118 days, mainly because of higher inventory. UPL says it is focused on turning that inventory into cash in the second half. For a broader framework on reading a results release like this one, see our guide on how to analyse quarterly results.

On funding, the company prepaid a $500 million term loan due in December 2026, using $400 million of refinancing that runs to FY32. It also noted that S&P moved UPL Corp’s outlook to Positive while affirming its ‘BB’ rating, and CRISIL moved UPL Ltd’s outlook to Stable from Negative, reaffirming AA+/A1+.

What it means

The quarter shows a company leaning on seeds and specialty chemicals while its largest platform, UPL Corporation, works through weak crop protection volumes. Margins are holding. Cash and debt are not improving yet, and that is the gap the second half needs to close. Separately, Advanta agreed to buy 99.98% of Egypt’s Misr Hytech Seed International for about $110 million, with completion expected on or before January 31, 2027, subject to approvals.

For context on how other chemical makers fared this season, see our note on Neogen Chemicals’ Q2 results, and our explainer on YoY vs QoQ growth for reading these comparisons.

Disclaimer: This article summarises a company filing for information only and is not investment advice. Figures are as reported by UPL Limited in its November 2, 2026 press release; percentage changes are year on year unless stated. Please consult a SEBI-registered investment adviser before making investment decisions.

Leave a Reply

Join the conversation

Commenting is open to registered readers. Sign up with just your email — no password needed, and it takes under a minute.

Sign up to comment Log in